Companies

Medtronic’s Valiant Thoracic Stent Graft has become the second device to be FDA approved for use in all descending thoracic aortic aneurysms without dissections.

Boston Scientific Corporation and the University of Rochester Medical Center have shown that improved programming of Boston Scientific dual-chamber ICD or CRT-D heart devices can reduce inappropriate therapy and risk of death.

Will they, won’t they? The current standoff between St.Jude and AorTech, the supplier of its seemingly rather effective Optim ICD coating material will either end in tears of nuptial joy or something rather more ugly as St.Jude wins its injunction against AorTech’s threatened termination of their supply agreement.

Just a month after taking the hot seat, Kevin Lobo has had something we Brits might call a cabinet reshuffle, bringing in a new man to replace himself in heading up the company’s vital orthopedics business.

Well well well. All the big players have renal denervation systems in development or already in the catalogue. Now, so does Boston Scientific with the year’s least surprising acquisition of Vessix Vascular.

Data from the St.Jude EnligHTN I multi-electrode renal denervation catheter study presented at the annual scientific meeting of the American Heart Association suggests blood pressure reduction is sustained at six months.

Sorin says its newly (U.S.) launched Mitroflow Valsalva Conduit allows for safer device manipulation during assembly and implantation, thus limiting cardiac surgery time

Sports med and Negative Pressure Wound Therapy are the only stars in the portfolio last quarter for Smith & Nephew, although profit performance strength suggests restructuring and disposals have kicked in.

Michael Carrel has been appointed as President and Chief Executive Officer of AtriCure, Inc., a leading manufacturer of cardiac surgical ablation systems for the treatment of atrial fibrillation(AF), and systems for the exclusion of the left atrial appendage.

sBioMed, which describes itself as an emerging leader in infection control, has announced that Stephen P. MacMillan, former Chairman and CEO of Stryker, has joined as Chief Executive Officer and become an owner of the company.

It seems like he’s been there for ages… because he has. Now after a year sorting out his previous responsibilities to former employer J&J among other things, Mike Mahoney formally takes the CEO and President reigns at Boston Scientific.

Boston Scientific Corporation has announced CE Mark approval for the Synergy™ Everolimus-Eluting Platinum Chromium Coronary Stent System featuring its ultra-thin abluminal bioabsorbable polymer coating which holds the promise of reducing late adverse events.

Data demonstrate high procedural success and low paravalvular leak for Medtronic’s new Engager TAVI offering in late-breaking trials session at the European Association for Cardio-Thoracic Surgery annual meeting.

FDA clearance of Medtronic’s Affinity Pixie® Oxygenation system provides Perfusionists with options for a broader range of patients. The system was CE marked in May 2010 so won’t be new to Europeans.

Clever non-invasive glucose monitor measures levels using light. The device is now CE marked for use as an adjunct to conventional invasive techniques.

DePuy Synthes Spine has announced new image guided instrumentation for two of its leading spine systems and has entered into a new partnership agreement with Brainlab, enabling both companies to offer integrated surgical navigation and imaging solutions.